Showing results (141-150 of 286) with videos related to

Sort By:
Pageof 29
Biorxiv : the Preprint Server for Biology|September 2, 2025
Autosomal Allelic Inactivation: Variable Replication and Dosage SensitivityMichael B Heskett, Athanasios E Vouzas, Brian Johnstone, et al.
Elife|July 8, 2026
Autosomal allelic inactivation at loci with variable replication timing and dosage sensitivityMichael B Heskett, Athanasios E Vouzas, Brian Johnstone, et al.
Cancer Cytopathology|July 20, 2012
Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasiaTerry K Morgan, Karin Hardiman, Christopher L Corless, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Imatinib targeting of KIT-mutant oncoprotein in melanomaXiaofeng Jiang, Jun Zhou, Noah K Yuen, et al.
Cancer Research|August 4, 2004
Protein Kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs)Anette Duensing, Nora E Joseph, Fabiola Medeiros, et al.
Cancer Research|November 30, 2014
Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug ResistanceNathalie Javidi-Sharifi, Elie Traer, Jacqueline Martinez, et al.
Cancer Medicine|January 10, 2014
Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activityBenjamin S Misemer, Amy P N Skubitz, J Carlos Manivel, et al.
Cell Cycle (Georgetown, Tex.)|December 24, 2015
ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer originDaria Fleyshman, Peter Cheney, Anda Ströse, et al.
Nature Communications|May 14, 2016
Patient-specific factors influence somatic variation patterns in von Hippel-Lindau disease renal tumoursSuzanne S Fei, Asia D Mitchell, Michael B Heskett, et al.
Gynecologic Oncology|May 11, 2026
Real-world genetic testing data of ovarian cancer patients: Informing counseling and risk reduction in patients over age seventyEliya Shachar, Gilat Rotkop, Roni Haas, et al.
Pageof 29